《细胞过继免疫治疗肿瘤的临床研究进展》ppt课件.pptVIP

《细胞过继免疫治疗肿瘤的临床研究进展》ppt课件.ppt

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
《细胞过继免疫治疗肿瘤的临床研究进展》ppt课件

细胞过继免疫治疗肿瘤的临床研究进展;细胞免疫治疗肿瘤的发展;国内细胞免疫治疗研究热潮;肿瘤的细胞免疫治疗 经过体外培养加工;CIK Cytokine induced killer;2009,Germany,Prof. Dr. Schmidt-Wolf 建立了CIK临床研究登记网站 ,目前收集发表的文章39篇,中国人发表26篇(占2/3)。 2011,J Cancer Res Clin Oncol. “Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)”. PubMed the keywords ‘‘CIK cells clinical trials’’,evaluated 11 studies(426人). 并与作者联系核实 涉及的杂志:Digestive and Liver Disease, Chinese Journal of Cancer, Anticancer Research, World Journal of Gastroenterology , Haematologica, British Journal of Cancer, Biology of Blood, and Marrow Transplantation. In some studies, abstracts were only available in Chinese. Unfortunately, these studies are often published only in Chinese. international standard ;Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC);Table 1 Tumor entity with number of respective patients, male-to-female ratio, andtherapeutic effects;Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors Dario Sangiolo, Italy Journal of Cancer 2011; 2: 363-36 ;Fig. 1. Disease-free survival curves of the three groups. Kaplan–Meier was employed to estimate the disease-free survival rates of the three groups. Logrank test shows a significantly higher rates in the CIK-I group (p = 0.001) and the CIK-II group (p = 0.004) than in the control group. No statistical significance was found between the CIK-I group and the CIK-II group (p = 0.345).;;A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma;Figure 1 Survival rates of patients after cytokine-induced killer cells immunotherapy plus chemotherapy and chemotherapy alone. CIK: Cytokineinduced killer.;World J Gastroenterol 2010 December 28; 16(48): 6155-6162 Jing-Ting Jiang, Yue-Ping Shen, Chang-Ping Wu, Yi-Bei Zhu, Wen-Xiang Wei, Lu-Jun Chen, Xiao Zheng,Jing Sun, Bin-Feng Lu, Xue-Guang Zhang 苏州大学;Cord blood-derived cytokine-induced

文档评论(0)

feixiang2017 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档